slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,539
Current window 103,261-103,290
Pages 3,685
Rows per page 30
Component
103,261-103,290 of 110,539
69
The slide uses a list-based framework to categorize software capabilities.Heliogen | Investor Day Presentation Deck | 80 slides · Heliogen
Conference presentation Investor relations 1 hit
71
The diagram illustrates the process flow from the solar field (DSGR) to the customer, including day/night thermal storage cycles.Heliogen | Investor Day Presentation Deck | 80 slides · Heliogen
Conference presentation Investor relations 1 hit
75
Includes a photo of the physical hardware, an isometric technical drawing, and a scale comparison diagram.Heliogen | Investor Day Presentation Deck | 80 slides · Heliogen
Conference presentation Investor relations 1 hit
76
The slide uses a process flow diagram to show the components of the power block.Heliogen | Investor Day Presentation Deck | 80 slides · Heliogen
Conference presentation Investor relations 1 hit
78
The diagram illustrates a process flow for high-temperature material processing using solar thermal energy.Heliogen | Investor Day Presentation Deck | 80 slides · Heliogen
Conference presentation Investor relations 1 hit
80
Heliogen | Investor Day Presentation Deck | 80 slidesHeliogen | Investor Day Presentation Deck | 80 slides · Heliogen
Conference presentation Investor relations 1 hit
03
Includes a circular photo of Shoshone Falls.Idacorp | Investor Presentation Deck | 9 slides · IDACORP
Conference presentation Investor relations Beat · Attention1 hit
05
The chart shows growth from 2018 through the 12 months ending Sept 30, 2022.Idacorp | Investor Presentation Deck | 9 slides · IDACORP
Conference presentation Investor relations Beat · InterestLoop · Cost Of Inaction1 hit
06
Idacorp | Investor Presentation Deck | 9 slidesIdacorp | Investor Presentation Deck | 9 slides · IDACORP
Conference presentation Investor relations Beat · DesireLoop · Cost Of Inaction1 hit
03
Imara | Mergers and Acquisitions Presentation Deck | 45 slidesImara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Loop · Golden Circle1 hit
06
Includes headshots for leadership team and lists for board, advisors, and investors.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Team1 hit
07
The slide uses a combination of bulleted achievements and a logo grid of FDA-approved drugs to establish credibility.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Team1 hit
09
The slide uses a split-screen layout to contrast clinical challenges with the specific reasons for treatment switching.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
14
The chart uses a broken axis to represent the significantly larger patient population for HER2 overexpressing cancers compared to mutations.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
15
The chart uses a logarithmic scale for selectivity. The right side provides a qualitative critique of competitor molecules.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · Problem1 hit
20
The slide uses a split-screen layout to contrast clinical challenges with the rationale for treatment switching.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
22
Includes clinical trial data and resistance mutation analysis.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
27
The table highlights key differentiators such as lower BCRP substrate status and improved plasma protein binding for ELVN-001.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
28
Includes both a competitive cellular phosphorylation table and a specific kinase selectivity table for ELVN-001.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank Beat · SolutionLoop · Cost Of Inaction1 hit
33
The chart uses a broken axis to represent the significantly larger patient population for HER2 overexpressing cancers compared to the initial focus areas.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
39
The slide uses a logarithmic scale for selectivity. The right side provides a qualitative critique of competitor molecules.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
40
Data shows ELVN-002 efficacy and safety profile compared to Tucatinib and Poziotinib.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
41
The slide compares efficacy (BLI signal) and PK (concentration over time) to demonstrate superior potency of ELVN-002 at lower exposures.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
42
Includes references to Li et al. Cancer Disc 2020 and Abraham et al. J Clin Oncol 2019.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
43
Includes a line chart showing concentration over time and a table summarizing safety margin folds at different doses.Imara | Mergers and Acquisitions Presentation Deck | 45 slides · Enliven Therapeutics / Imara
Press release Investment bank 1 hit
07
The slide highlights the company's competitive moat through IP and brand licensing.Innovative Eyewear | Investor Presentation Deck | 21 slides · Innovative Eyewear
Pitch deck Investor relations Beat · Solution1 hit
10
The slide positions Vyrb as a competitor/alternative to Clubhouse and Discord, emphasizing hands-free audio posting.Innovative Eyewear | Investor Presentation Deck | 21 slides · Innovative Eyewear
Pitch deck Investor relations Beat · Solution1 hit
15
Innovative Eyewear | Investor Presentation Deck | 21 slidesInnovative Eyewear | Investor Presentation Deck | 21 slides · Innovative Eyewear
Pitch deck Investor relations Beat · Market Size1 hit
20
Innovative Eyewear | Investor Presentation Deck | 21 slidesInnovative Eyewear | Investor Presentation Deck | 21 slides · Innovative Eyewear
Pitch deck Investor relations Loop · Why Now1 hit
03
The slide uses a circular diagram to represent corporate values and differentiators, contrasting this with a bulleted list of arguments against a third-party proposal.KLA | ESG Presentation Deck | 6 slides · KLA
Conference presentation Investor relations Beat · Preempt RebuttalLoop · Cost Of Inaction1 hit